ARK Genomic Revolution ETF (ARKG) is a ARK ETF with a 0.75% expense ratio, 35 holdings and $2.2B in net assets. Largest sector: Healthcare (100%).
Fee
0.75%
expense ratio
Net assets
$2.2B
Launched
Oct 31, 2014
Holdings
35
as of Oct 23, 2026
Top 10 weight
57.9%
largest ten holdings
Largest sector
Healthcare
100.0%
Yield
—
Benchmark
—
ARKG's holdings are as of Oct 23, 2026.
Healthcare
100.0%
1
TXG
10X GENOMICS INC-CLASS A
8.58%
2
TEM
Tempus AI Class A
7.88%
3
TWST
TWIST BIOSCIENCE
7.85%
4
CRSP
CRISPR THERAPEUTICS AG
5.53%
5
ILMN
ILLUMINA
5.01%
6
ABSI
Absci
4.98%
7
NTRA
Natera
4.98%
8
GH
Guardant Health
4.93%
9
LLY
ELI LILLY
4.29%
10
CDNA
CareDx
3.89%
11
VCYT
VERACYTE
3.59%
12
BEAM
BEAM THERAPEUTICS
3.49%
13
NRIX
Nurix Therapeutics
2.88%
14
CMPS
COMPASS PATHWAYS
2.85%
15
RXRX
RECURSION PHARMACEUTICALS-A
2.74%
16
SDGR
Schrodinger Inc
2.55%
17
ADPT
Adaptive Biotechnologies
2.24%
18
IONS
Ionis Pharmaceuticals
1.92%
19
NTLA
INTELLIA THERAPEUTICS
1.80%
20
WGS
GENEDX HOLDINGS
1.74%
21
BFLY
Butterfly Network Class A
1.68%
22
ALMR
Alamar Biosciences
1.67%
23
ARCT
Arcturus Therapeutics Holdings
1.52%
24
PRME
Prime Medicine
1.45%
25
PACB
PACIFIC BIOSCIENCES OF CALIF
1.16%
1–25 of 35
Funds listed by how much of their largest holdings they share with ARKG — not a ranking.
Data from ARK; prices and returns from market data. Page updated October 29, 2026. Holdings and figures change over time. For information only — not investment advice.